Difference between revisions of "Other CNS embryonal tumours"

From Libre Pathology
Jump to navigation Jump to search
(DDx)
(Clinics)
Line 37: Line 37:
Currently it is a exlcusion criteria encompassing four morphological subgroups
Currently it is a exlcusion criteria encompassing four morphological subgroups
*CNS neuroblastomas  
*CNS neuroblastomas  
**often infants.
**Tumors can be huge.
*CNS ganglioneuroblastomas.
*CNS ganglioneuroblastomas.
** often characterized by FOXR2 fusions: ''CNS neuroblastoma with FOXR2 activation (NB‐FOXR2)''
** often characterized by FOXR2 fusions: ''CNS neuroblastoma with FOXR2 activation (NB‐FOXR2)''

Revision as of 11:00, 4 February 2020

Other CNS embryonal tumours
Diagnosis in short

Other CNS embryonal tumorH&E stain.

Synonyms CNS-PNET
LM DDx small round blue cell tumours
IHC S-100 +ve, Syn +/-ve
Site brain, spinal cord

Prevalence rare - typically in children and young adults
Prognosis poor (WHO Grade IV)


Other CNS embryonal tumor, was introduced in the WHO 2016 classification of CNS tumors. Some of these tumors of this category has been previously designated as CNS-PNET but this terminology has been abandoned.

General

Other CNS embryonal tumours are a group of primitive neuroeptithelial tumors that are to be classified in distinct molecular groups in the future. Currently it is a exlcusion criteria encompassing four morphological subgroups

  • CNS neuroblastomas
    • often infants.
    • Tumors can be huge.
  • CNS ganglioneuroblastomas.
    • often characterized by FOXR2 fusions: CNS neuroblastoma with FOXR2 activation (NB‐FOXR2)
  • CNS medulloepithelioma.
    • but absence of C19MC alteration, otherwise classified as ETMR
  • CNS embryonal tumour, NOS
    • Similarities to astroblastoma: High‐grade neuroepithelial tumours with MN1 alteration (HGNET‐MN1)
    • NUTM1-positive IHC: Ewing's sarcoma family tumour with CIC alteration (EFT‐CIC)
    • BCOR-positive IHC: HGNET BCOR‐altered neuroepithelial tumours

Currently four distinct subtypes can be discriminated by molecular analysis: NB-FOXR2, HGNET-MN1, EFT-CIC and HGNET-BCOR.[1]

Histology

CNS neuroblastoma:

  • Groups of neurocytic cells.
  • Variable neuropil-rich stroma.
  • Small round blue cells.

HGNET-BCOR:

  • Circumscribed growth.
  • Perivascular pesudorosettes.
  • Fibrillary areas resembling glioma.
  • Palisading necrosis.
  • Absence of microvascular proliferation.

IHC

CNS Ganglioneuroblastoma + Neuroblastoma

  • Syn -/+ve.
  • Vim -ve.
  • GFAP usu -ve.
  • MIB-1 usu high.

Medulloepthelioma

  • Syn +/-ve.
  • NF +/-ve.
  • GFAP usu -ve.
  • CK may be focally +ve.

HGNET-BCOR [2]

  • OLIG variable +ve.
  • BCOR +ve.
  • Syn -ve.
  • GFAP -ve.
  • EMA: dots +ve.
  • NEUN +/-ve.

DDx:

  1. "New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs". Cell 164 (5): 1060–1072. February 2016. doi:10.1016/j.cell.2016.01.015. PMC 5139621. PMID 26919435. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139621/.
  2. "High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis". Brain Pathol. 30 (1): 46–62. January 2020. doi:10.1111/bpa.12747. PMID 31104347.